| ID | Name | CAS | Properties |
logPoct/wat |
| 45-460-1 |
3-Amino-2,3-dihydrobenzoic acid, N-dimethylaminomethylene-, methyl ester
|
|
3 | 1.004 |
| 45-501-5 |
O-Methyl-O-(1,1-difluoro-2-bromoethyl)-N-metyl-phosphorothioamidate
|
|
3 | 2.081 |
| 45-604-1 |
7«alpha»-hydroxy, 3-oxy-4-cholenoate, methyl ester-trimethylsilyl ether
|
|
3 | 8.410 |
| 45-797-8 |
3«beta»,4«beta»,12«alpha»-trihydroxy-5«beta»-cholanoic acid acid, methyl ester-trimethylsilyl-ether derivative
|
|
3 | 9.115 |
| 45-936-3 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, MO-TMS, (syn,anti)
|
|
3 | 8.207 |
| 46-049-7 |
11H-Pyrido[2,1-b]quinazolin-11-one, 6,7,8,9-tetrahydro
|
|
3 | 1.733 |
| 46-138-8 |
«alpha»-D-Galactopyranose, 1,2,3,4,6-pentakis-O-(trimethylsilyl)-
|
32166-80-6 |
3 | 6.075 |
| 46-139-7 |
4-Cyclopropyl-6-methyl-N-phenyl-N-trifluoroacetyl-pyrimidin-2-amine
|
|
3 | 3.889 |
| 46-349-4 |
3«alpha»,6«beta»,7«beta»-Trihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 9.115 |
| 46-427-7 |
(.+/-.)-2-Phenylbutyric acid, dimethyl(3,3,3-trifluoropropyl)silyl ester
|
|
3 | 4.881 |
| 46-472-7 |
4-Quinolinol, 4-ethenyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«beta»,8a«alpha»)-
|
20431-91-8 |
3 | 2.186 |
| 46-541-0 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 2,6-dimethyl
|
|
3 | -0.629 |
| 46-580-7 |
5,5-Pentamethylene-2-phenyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 2.887 |
| 46-758-0 |
Glutarimide, 3-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, semicarbazone
|
3428-71-5 |
3 | 0.497 |
| 46-896-7 |
5-«alpha»-Pregnan-3-«beta»,15 or 16-diol-20-one, MeTMS
|
|
3 | 7.284 |
| 47-116-1 |
Pyrazolo[1,5-d][1,2,4]triazin-3-one, 2,6,7,7-tetramethyl
|
|
3 | 0.474 |
| 47-270-0 |
N2-Cyclopropyl-1,3,5-triazine-2,4,6-triamine N2,N4,N6-tris(trifluoroacetate)
|
|
3 | 1.931 |
| 47-312-3 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,12-«alpha»-trihydroxy, methyl ester, TMS
|
|
3 | 9.115 |
| 47-494-2 |
24-Nor-3«alpha»,7«alpha»-dihydroxy-5«beta»-cholanoic acid, MeTMS
|
|
3 | 7.895 |
| 47-524-8 |
2-Butenoic acid, 2-methyl-, 2,3,5,7a-tetrahydro-7-(hydroxymethyl)-1H-pyrrolizin-1-yl ester, [1S-[1«alpha»(Z),7a«alpha»]]-
|
723-78-4 |
3 | 0.871 |
| 47-555-4 |
5«alpha»-Androstane-3«alpha»,17«beta»-diol,bis-TMS
|
|
3 | 7.469 |
| 47-803-8 |
N-(1,2-Dimethylpropyl)-N,N'-bis(pentafluoropropionyl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 4.719 |
| 47-980-2 |
5«alpha»-Androstane-2«beta»,3«alpha»,17«beta»-triol, TMS
|
|
3 | 8.299 |
| 48-077-4 |
2-Pyrazoline-5-one, 4,4-dimethyl-3-isopropyl-1-phenyl-
|
92292-40-5 |
3 | 3.071 |
| 48-631-8 |
2H-1,3,4-Thiadiazine, tetrahydro-2,2,4,6-tetramethyl-
|
|
3 | 1.294 |
| 48-702-9 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-cyclopentyl-phosphorothioamidate
|
|
3 | 3.238 |
| 48-877-6 |
1,2,3,4,6,7,8,9-Octahydro-pyrido[2,1-b]quinazolin-11-one
|
|
3 | 1.458 |
| 48-923-4 |
5-Methyl-2H-pyrazole-3-carboxylic acid, 2-isopropenyl hydrazide
|
|
3 | 0.362 |
| 48-928-9 |
3«beta»,16«alpha»,17«alpha»-Tris(trimethylsiloxy)androst-5-ene
|
25876-85-1 |
3 | 8.219 |
| 48-988-3 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-methyl-phosphorothioamidate
|
|
3 | 1.925 |
| 49-434-6 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 9-methyl
|
|
3 | 1.141 |
| 49-838-8 |
5,5-Pentamethylene-2-phenyl-4-propionyl-1,3,4-oxadiazoline
|
|
3 | 3.277 |
| 49-879-3 |
2-(4-Allyl-2,6-dimethoxy-phenoxy)-1 -(3,4-dimethoxy-phenyl)-propan-1-ol, TMS
|
|
3 | 5.810 |
| 49-894-6 |
Isonipecotic acid, N-(2,6-difluoro-3-methylbenzoyl)-, pentyl ester
|
|
3 | 3.859 |
| 50-014-0 |
6-Methyl-3,5-heptadien-2-one, PFBO # 2
|
|
3 | 4.797 |
| 50-097-9 |
allo-Cholanic acid, 7«beta»,12«beta»-dihydroxy, Me-TMS
|
|
3 | 8.285 |
| 50-303-9 |
1,3-Dimethyl-5-(3-oxocyclohexen-1-yl)hexahydropyrimidine-2,4,6-trione
|
|
3 | 0.332 |
| 50-350-7 |
5-Ethyl-5-methyl-2-(1-methylethyl)-4-isobutanoyl-1,3,4-oxadiazoline
|
|
3 | 2.597 |
| 50-502-8 |
3-[((1,1,3,3-Tetramethyl-3-[(3Z)-non-3-en-1-yloxy]disiloxanyl)oxy)methyl]pyridine
|
|
3 | 5.562 |
| 50-651-3 |
benzaldehyde oxime, 2-hydroxy, 3-chloro, 5-(1,1,3,3-tetramethylbutyl)
|
|
3 | 4.567 |
| 50-920-4 |
Ergosta-5,7,9(11),22-tetraen-3«beta»-ol, TMS
|
|
3 | 9.110 |
| 51-118-4 |
3,7-Diazabicyclo[3.3.1]nonane, 3,7-dimethyl-
|
14789-33-4 |
3 | 0.500 |
| 51-206-6 |
5-«beta»-Pregnan-3-«alpha»,20-«alpha»,21-triol, MeTMS
|
|
3 | 8.937 |
| 51-266-0 |
1-Methyl-2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one
|
|
3 | 1.904 |
| 51-432-5 |
Cholanic acid, 3«beta»,7«alpha»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 51-590-0 |
1-Cyclopentadienyl-5-phenyl-1,1,3,3,5,5-hexamethyl trisiloxane
|
|
3 | 4.535 |
| 51-610-7 |
5-Cholesten-3-«beta»,7-«alpha»,25,26-tetrol, TMS
|
|
3 | 11.884 |
| 51-638-7 |
Thiazolo[3,2-a]pyridinium, 2,3-dihydro-8-hydroxy-, hydroxide, inner salt
|
23003-45-4 |
3 | 0.153 |
| 51-692-7 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-pentyl-phosphorothioamidate
|
|
3 | 3.485 |
| 52-092-2 |
2-Ethyl-5,5-dimethyl-5-propionyl-1,3,4-oxadiazoline
|
|
3 | 1.715 |
| 52-103-9 |
N-(2-Furylmethyl)-N-tert-butyldimethylsilyl-9H-purin-6-amine
|
|
3 | 3.476 |
| 52-132-7 |
Propanoic acid, 3-[N-(2-formyl-5-methyl-1-pyrrolyl)]
|
|
3 | 1.084 |
| 52-159-8 |
1,6-Diazatetracyclo[4.3.27,9.12,5]dodecane
|
105090-34-4 |
3 | 1.375 |
| 52-331-6 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (oxo-HO-toluol-), AC
|
|
3 | 3.284 |
| 52-425-2 |
1,3,5,2,4,6-Triazatriphosphorine, 2,2,4,4,6-pentabromo-6-chloro-2,2,4,4,6,6-hexahydro-
|
|
3 | 8.052 |
| 52-489-2 |
(3,5-BIS-CYANOMETHYL-[1,3,5]TRIAZINAN-1-YL)-ACETONITRILE
|
|
3 | -0.651 |
| 52-553-0 |
Thiazolo[3,2-c]pyrimidin-4-ium, 2,3-dihydro-8-hydroxy-5-methyl-, hydroxide, inner salt
|
|
3 | -0.143 |
| 52-726-8 |
4,5,6,7-Tetrahydropyrazolo[1,5-d][1,2,4]-triazin-4-one, 5-butyl-2,6-dimethyl
|
|
3 | 0.883 |
| 52-806-9 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M (oxo-HO-alkyl-), AC
|
|
3 | 2.901 |
| 53-012-9 |
Propanoic acid, 3-[N-(2-formyl-5-(hydroxymethyl)-1-pyrrolyl)]
|
|
3 | 0.268 |
| 53-117-3 |
Valine-glutamine-tryptophan-leucine, N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative
|
|
3 | 3.794 |
| 53-148-9 |
2H-Pyrido[3,2,b]-1,4-oxazin-3[4H]-one
|
|
3 | 0.412 |
| 53-684-4 |
5-«alpha»-Pregnan-3-«beta»-15x-diol-20-one, TMS
|
|
3 | 7.284 |
| 53-784-3 |
1,3,5,2,4,6-Triazatriphosphorine, 2-bromo-2,4,4,6,6-pentachloro-2,2,4,4,6,6-hexahydro-
|
14740-93-3 |
3 | 7.427 |
| 53-798-8 |
Silane, dimethyldi(2,2,3,3,4,4,5,5-octafluoropentyloxy)-
|
|
3 | 6.063 |
| 53-802-2 |
Benzeneacetic acid, «alpha»-[[(trimethylsilyl)oxy]methyl]-, 9-methyl-3-oxa-9-azatricyclo[3.3.1.0(2,4)]non-7-yl ester, [7(S)-(1«alpha»,2«beta»,4«beta»,5«alpha»,7«beta»)]-
|
55373-83-6 |
3 | 2.777 |
| 53-911-1 |
5-Methylaceto-5'-(3-buten-1-ynyl)-2,2'-bithienyl
|
|
3 | 4.077 |
| 53-985-0 |
6-Chloro-N-sec-butyl-N'-heptafluorobutryl-1,3,5-triazine-2,4-diamine
|
|
3 | 3.507 |
| 54-026-3 |
2,6-Pyridinedicarboxylic acid, ethyl 1-methoxydec-4-yl ester
|
|
3 | 4.181 |
| 54-458-4 |
1,3,4-Oxadiazol-2(3h)-one, 3-acetyl-5-(5-nitro-2-furyl)-
|
|
3 | 0.665 |
| 54-560-0 |
2,3,5,6,7,8,9,10-Octahydro-1H-cycloocta[d]pyrrolo[1,2-a]pyrimidin-11-one
|
|
3 | 1.848 |
| 54-652-8 |
7H-pyrrolo[2,3-d]pyrimidine, 4-amino-7-[3-(hydroxymethyl)cyclopentyl]-
|
|
3 | 1.347 |
| 54-881-4 |
1,2,3,4,6,7,8,9,10,11-Decahydro-4a,12-diaza-cycloocta[b]naphthalen-5-one
|
|
3 | 2.239 |
| 54-928-2 |
5«alpha»-Androstane-2«alpha»,3«alpha»,17«beta»-triol, TMS
|
|
3 | 8.299 |
| 55-093-8 |
5-Ethyl-5-methyl-4-acetyl-1,3,4-oxadiazoline
|
|
3 | 0.935 |
| 55-233-2 |
4-Quinolinol,1-ethyl-4-ethynyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«alpha»,8a«beta»)
|
38463-54-6 |
3 | 2.024 |
| 55-267-5 |
2,3'-Bipyridine, 1'-acetyl-1',3,4,4',5,5',6,6'-octahydro-
|
|
3 | 2.137 |
| 55-320-5 |
O-Ethyl-O-(1,1-difluoro-2-chloroethyl)-N-butyl-phosphorothioamidate
|
|
3 | 3.485 |
| 55-372-8 |
4-Quinolinol,1,4-diethyldecahydro-2-methyl-(2«alpha»,4«alpha»,4a«beta»,8a«alpha»)
|
38463-62-6 |
3 | 2.800 |
| 55-407-9 |
2-Butenoic acid, 3-methyl-2-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
|
3 | 3.510 |
| 55-599-7 |
2(1H)-Pyridinone, 3-acetyl-4-hydroxy-1,6-dimethyl-
|
7202-55-3 |
3 | 0.602 |
| 55-862-4 |
5.beta.-Cholestane-3.alpha.,7.alpha.,26-triol, TMS
|
|
3 | 10.599 |
| 56-086-5 |
2,3-Dihydro-1H-4,8a-diaza-cyclopenta[b]naphthalen-9-one
|
|
3 | 1.183 |
| 56-112-5 |
5«beta»-Stigmastanol (24«beta»-ethyl-5«beta»-cholestan-3«beta»-ol), TMS
|
|
3 | 9.964 |
| 56-323-1 |
N-(1,2-Dimethylpropyl)-N,N'-bis(trifluoroacetyl)-N'-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine
|
|
3 | 3.449 |
| 56-452-8 |
R,S-4'-methyl-«alpha»-pyrrolidinohexanophenone-M, (HO-alkyl-) isomer-1, AC
|
|
3 | 3.374 |
| 56-883-0 |
3-.beta.,7-.alpha.-Dihydroxy-5-cholenoic acid, methyl ester, TMS
|
|
3 | 8.205 |
| 57-058-5 |
3-[(Pyrrol1,1,3,3-tetramethyl-3-[(1-methylpentyl)oxy]disiloxanylmorphooxy)methyl]pyridine
|
|
3 | 4.614 |
| 57-084-6 |
Isonipecotic acid, N-(2,4,5-trifluoro-3-methoxybenzoyl)-, heptyl ester
|
|
3 | 4.478 |
| 57-606-6 |
4-Quinolinol, 4-ethyldecahydro-1,2-dimethyl-, (2«alpha»,4«alpha»,4a«beta»,8a«alpha»)-
|
20422-68-8 |
3 | 2.410 |
| 57-634-5 |
(24R)-24-ethyl-5«alpha»-cholestan-3«beta»,25-diol, DMESI
|
|
3 | 11.718 |
| 57-651-6 |
Azobenzene, 2-chloro-4-nitro-4'-[2-(hydroxyethyl)(ethyl)amino]-
|
|
3 | 4.482 |
| 57-713-7 |
Trimethylsilyl 2-[(3,5,6-trichloro-2-pyridyl)oxy]acetate
|
|
3 | 3.799 |
| 57-805-5 |
4H-Pyrido[1,2-a]pyrimidin-4-one, 6-methyl
|
|
3 | 1.003 |
| 57-831-6 |
Isonipecotic acid, N-(2,5-di(trifluoromethyl)benzoyl)-, nonyl ester
|
|
3 | 6.870 |
| 57-900-9 |
4-(tert-Butylamino)-6-ethyl-6-trifluoroacetylamino-5H-1,3,5-triazin-2-one
|
|
3 | 0.809 |
| 57-905-4 |
Cholanic acid, 3«beta»,7«beta»,12«alpha»-trihydroxy, Me-TMS
|
|
3 | 9.115 |
| 57-930-6 |
O-Methyl-O-(1,1-difluoro-2-chloroethyl)-N-cyclopropyl-phosphorothioamidate
|
|
3 | 2.457 |
| 58-050-2 |
3-oxy-7«alpha»-hydroxy-4-cholestenoate, methyl ester-trimethylsilyl ether
|
|
3 | 9.356 |
| 58-110-5 |
5«beta»-Androstane-3«beta»,17«beta»-diol,bis-TMS
|
|
3 | 7.469 |
|
« Previous Results
Next Results »
|